Accessible Search Form           Advanced Search

  • PRINT  | 

Sickle Cell Program

The sickle cell program was created in 2011 to accelerate the translation of basic discovery to therapeutic application. The program is focused on pre-clinical and clinical testing of drugs and innovative compounds that reduce polymerization, improve red cell rheology, or induce fetal hemoglobin; elucidating genetic modifiers that may affect disease severity; studying and preventing end organ damage that may lead to increased morbidity and mortality; and the development of potentially curative stem cell transplantation strategies.



Program Staff

 

Constance Noguchi
Senior Investigator
Sickle Cell Program


P: +1 301 496 1163
F: +1 301 451 5459
cnoguchi@helix.nih.gov

Principal Investigator thumbnail image

John Tisdale
Director
Sickle Cell Program


P: +1 301 402 6497
F: +1 301 451 5459
johntis@mail.nih.gov

 

Hans Ackerman
Senior Investigator
Sickle Cell Program


P: +1 301 402 5652
F: +1 301 451 5459
hans.ackerman@nih.gov

 

William Eaton
Senior Investigator
Sickle Cell Program


P: +1 301 496 6030
F: +1 301 451 5459
eaton@helix.nih.gov

 

Jim Hofrichter
Special Volunteer
Sickle Cell Program


P: +1 301 496 6033
F: +1 301 451 5459
jameshof@mail.nih.gov

 

Alan Schechter
Senior Investigator
Sickle Cell Program


P: +1 301 496 5408
F: +1 301 451 5459
aschecht@helix.nih.gov


Last Updated: September 26, 2014